We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

157 hedge funds and large institutions have $437M invested in PDL BioPharma, Inc. in 2019 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 50 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $347M → $437M (+$90.1M)

25% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 20

2% more funds holding

Funds holding: 154 → 157 (+3)

10% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 50

Holders
157
Holders Change
+3
Holders Change %
+1.95%
% of All Funds
3.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
45
Reduced
50
Closed
20
Calls
$338K
Puts
–
Net Calls
+$338K
Net Calls Change
+$240K

Top Buyers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$8.3M
2
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
+$5.68M
3
WG
Winton Group
United Kingdom
+$4.51M
4
OAM
Oxford Asset Management
United Kingdom
+$3.6M
5
Bank of America
Bank of America
North Carolina
+$3.27M

Top Sellers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
-$21.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.86M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.2M
4
KIM
Kestrel Investment Management
California
-$4.01M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$3.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$3.62M – – –
Nomura Holdings
27
Nomura Holdings
Japan
$3.53M +$110K +32,539 +4%
Prudential Financial
28
Prudential Financial
New Jersey
$3.14M +$1.22M +360,739 +75%
UBS Group
29
UBS Group
Switzerland
$3.1M -$1.42M -420,346 -34%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.69M -$3.78K -1,120 -0.2%
Skandinaviska Enskilda Banken (SEB)
31
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.64M -$201K -59,600 -8%
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$2.56M +$263K +78,030 +13%
Credit Agricole
33
Credit Agricole
France
$2.49M -$346K -102,568 -13%
Federated Hermes
34
Federated Hermes
Pennsylvania
$2.39M -$334K -98,827 -13%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$2.31M -$71.2K -21,100 -3%
WFI
36
West Family Investments
California
$2.23M -$271K -80,200 -12%
AllianceBernstein
37
AllianceBernstein
Tennessee
$2.21M +$426K +126,238 +27%
Two Sigma Investments
38
Two Sigma Investments
New York
$2.18M -$39.6K -11,716 -2%
RC
39
RBF Capital
California
$2.12M -$78K -23,090 -4%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.99M -$331K -98,188 -16%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$1.88M -$323K -95,659 -16%
AA
42
Ancora Advisors
Ohio
$1.6M -$142K -42,203 -9%
SFM
43
Systematic Financial Management
New Jersey
$1.33M -$200K -59,220 -14%
AA
44
ALPS Advisors
Colorado
$1.31M +$51.4K +15,222 +5%
Wells Fargo
45
Wells Fargo
California
$1.26M -$18.2K -5,387 -2%
TA
46
Teachers Advisors
New York
$1.19M – – –
KCM
47
Kennedy Capital Management
Missouri
$1.17M -$21.7M -6,422,158 -95%
DCM
48
Dupont Capital Management
Delaware
$1.15M +$371K +109,978 +55%
TCIM
49
TIAA CREF Investment Management
New York
$1.13M – – –
MF
50
Magnetar Financial
Illinois
$1.06M +$627K +185,599 +184%
1
2
3 4 5

PDLI Hedge Fund Activity: Q1 2019 in Review

157 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q1 2019, worth a combined $437M — up 26% from $347M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new PDLI positions and 20 closed out — a net gain of 5 holders — while 45 added to existing stakes and 50 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $8.3M. The largest seller was Kennedy Capital Management, cutting an estimated $21.7M.

  • 157 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q1 2019, up from 154 in Q4 2018.
  • Funds reported $437M of PDL BioPharma, Inc. stock for Q1 2019, up 26% quarter-over-quarter.
  • 25 funds opened new PDL BioPharma, Inc. positions in Q1 2019 and 20 closed out, a net change of +5 holders.
  • The largest PDL BioPharma, Inc. buyer in Q1 2019 was Arrowstreet Capital, an estimated $8.3M added.
  • The largest PDL BioPharma, Inc. seller in Q1 2019 was Kennedy Capital Management, an estimated $21.7M sold.

Based on aggregated 13F filings for Q1 2019.